Dr Reddy's Laboratories Income Taxes 2010-2024 | RDY
Dr Reddy's Laboratories annual/quarterly income taxes history and growth rate from 2010 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
- Dr Reddy's Laboratories income taxes for the quarter ending December 31, 2024 were $0.056B, a 3.53% increase year-over-year.
- Dr Reddy's Laboratories income taxes for the twelve months ending December 31, 2024 were $0.217B, a 7.93% increase year-over-year.
- Dr Reddy's Laboratories annual income taxes for 2025 were $0.231B, a 18.85% increase from 2024.
- Dr Reddy's Laboratories annual income taxes for 2024 were $0.194B, a 4.3% increase from 2023.
- Dr Reddy's Laboratories annual income taxes for 2023 were $0.186B, a 61.74% increase from 2022.
Dr Reddy's Laboratories Annual Income Taxes
(Millions of US $) |
| 2025 |
$231 |
| 2024 |
$194 |
| 2023 |
$186 |
| 2022 |
$115 |
| 2021 |
$125 |
| 2020 |
$-19 |
| 2019 |
$53 |
| 2018 |
$70 |
| 2017 |
$40 |
| 2016 |
$108 |
| 2015 |
$96 |
| 2014 |
$85 |
| 2013 |
$90 |
| 2012 |
$83 |
| 2011 |
$31 |
| 2010 |
$22 |
| 2009 |
$0 |
Dr Reddy's Laboratories Quarterly Income Taxes
(Millions of US $) |
| 2024-12-31 |
$56 |
| 2024-09-30 |
$68 |
| 2024-06-30 |
$59 |
| 2024-03-31 |
$34 |
| 2023-12-31 |
$54 |
| 2023-09-30 |
$52 |
| 2023-06-30 |
$54 |
| 2023-03-31 |
$41 |
| 2022-12-31 |
$47 |
| 2022-09-30 |
$62 |
| 2022-06-30 |
$35 |
| 2022-03-31 |
$19 |
| 2021-12-31 |
$36 |
| 2021-09-30 |
$37 |
| 2021-06-30 |
$23 |
| 2021-03-31 |
$35 |
| 2020-12-31 |
$36 |
| 2020-09-30 |
$13 |
| 2020-06-30 |
$40 |
| 2020-03-31 |
$-6 |
| 2019-12-31 |
$6 |
| 2019-09-30 |
$-46 |
| 2019-06-30 |
$27 |
| 2019-03-31 |
$22 |
| 2018-12-31 |
$13 |
| 2018-09-30 |
$11 |
| 2018-06-30 |
$7 |
| 2018-03-31 |
$11 |
| 2017-12-31 |
$40 |
| 2017-09-30 |
$16 |
| 2017-06-30 |
$3 |
| 2017-03-31 |
$2 |
| 2016-12-31 |
$18 |
| 2016-09-30 |
$13 |
| 2016-06-30 |
$7 |
| 2016-03-31 |
$25 |
| 2015-12-31 |
$27 |
| 2015-09-30 |
$29 |
| 2015-06-30 |
$27 |
| 2015-03-31 |
$11 |
| 2014-12-31 |
$40 |
| 2014-09-30 |
$20 |
| 2014-06-30 |
$25 |
| 2014-03-31 |
$22 |
| 2013-12-31 |
$41 |
| 2013-09-30 |
$13 |
| 2013-06-30 |
$9 |
| 2013-03-31 |
$37 |
| 2012-12-31 |
$16 |
| 2012-09-30 |
$30 |
| 2012-06-30 |
$7 |
| 2012-03-31 |
$19 |
| 2011-12-31 |
$48 |
| 2011-09-30 |
$14 |
| 2011-06-30 |
$3 |
| 2011-03-31 |
$13 |
| 2010-12-31 |
$3 |
| 2010-09-30 |
$7 |
| 2010-06-30 |
$8 |
| 2010-03-31 |
$11 |
| 2009-12-31 |
$-17 |
| 2009-09-30 |
$12 |
| 2009-06-30 |
$15 |
| 2009-03-31 |
$3 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$12.154B |
$3.811B |
|
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
|
